Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Heart Apoptosis in CABG
NCT04323852Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2017
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Vitamin D with Placebo (2 arms). Primary endpoints: Caspase 2 Enzyme Activity, Caspase 3 Enzyme Activity and 4 more. Started Sep 2017; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT04323852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04323852.